Erectile DysfunctionPREPAREDNCT00743613
Predicting Peripheral Arterial Disease in Men With Erectile Dysfunction
An observational study of Erectile Dysfunction and Peripheral Arterial Disease, run by Bruton Avenue Family Practice at 5 sites in United States.
Trial summary
Erectile dysfunction is a common complaint and is found frequently in men with hyperlipidemia, hypertension, diabetes and those who smoke. ED may also be an early warning of peripheral arterial disease. Read more about this study
- Who is it for?
- Ages 50 years and older, men onlyHealthy volunteers can take part
- Conditions the study is for
- Erectile Dysfunction, Peripheral Arterial Disease
- What is being tested?
- Sexual Health Inventory for Men (SHIM) and Ankle-Brachial Index (ABI)
- Type of treatment
- Surgery or procedure, Lifestyle or therapy programme
- How many people
- 175 participants
- Where
- 5 sitesUnited States
- Study dates
- Feb 2005to May 2008
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 years and older
- Men only
- Healthy volunteers accepted
- Adult, Older adult
Study population: Men 50 years old or older with either diabetes, hypertension, hyperlipidemia and/or a history of tobacco use.
Who may be able to join
- Men 50 years old or older
- Must have a history of diabetes, hypertension, hyperlipidemia and/or a history of tobacco use
Who cannot join
- Men younger than 50 years of age
- No co-morbid condition such as diabetes, hypertension, hyperlipidemia and/or tobacco use.
Trial locations and contacts
5 sites in 1 country.
5 sites in 1 country
United States5 sites
UMass, Fitchburg Family Medicine Center
Fitchburg, Massachusetts, 01420
Mercury West Family Practice
Hampton, Virginia, 23666
Bruton Avenue Family Practice
Newport News, Virginia, 23601
Hilton Family Practice
Newport News, Virginia, 23601
Williamsburg Medical Arts-Family Medicine
Williamsburg, Virginia, 23185
About this study
Erectile dysfunction is a common complaint and is found frequently in men with hyperlipidemia, hypertension, diabetes and those who smoke. ED may also be an early warning of peripheral arterial disease. This study is designed to look for a relationship between the degree of ED and the presence of PAD when associated with co-morbid conditions.
Read the detailed description
Erectile dysfunction (ED) is a common complaint in the primary care office. It is frequently found in men with hyperlipidemia, hypertension, or diabetes, and may also be an early warning of peripheral arterial disease. We looked for a relationship between the degree of ED and the presence of PAD as measured by the Ankle Brachial Index (ABI) associated with co-morbid conditions. Men over the age of 50 with hyperlipidemia, diabetes, hypertension, or tobacco use were asked to complete a Sexual Health Inventory for Men (SHIM). An ABI was measured using a hand held Doppler. 175 men from two urban and three suburban Family Practices in Tidewater Virginia participated. Outcome measures included SHIM scores, ABI, Systolic Blood Pressure, LDL, Hemoglobin A1C and tobacco use. Moderate or severe erectile dysfunction (SHIM < 11.0) was identified in 44% of participants. More than 12.5% of men with severe ED (SHIM < 7.0) had an ABI positive for PAD at 0.95 or less. The results were adjusted for the presence of hyperlipidemia, hypertension, diabetes and tobacco use. Men with hypertension did not demonstrate a significant increase in the frequency of PAD compared to diabetics or smokers. Neither race nor age was found to increase the prevalence of ED. The complaint of erectile dysfunction in men over age 50 should prompt a physician to consider peripheral arterial disease. A simple self-administered SHIM test should help identify men at risk for PAD and suggest further evaluation if the score is 7.0 or less.
- Conditions
- Erectile Dysfunction, Peripheral Arterial Disease
- Being tested
- Sexual Health Inventory for Men (SHIM), Ankle-Brachial Index (ABI)
- Keywords
- Erectile Dysfunction, ED, Peripheral Arterial Disease, PAD, Ankle-Brachial Index, ABI
- Medical subject headings
- Erectile Dysfunction, Peripheral Arterial Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sexual Health Inventory for Men (SHIM)Behavioural
Also called SHIM, Sexual Health Inventory for Men
Five question test with maximum score of 25 points administered on the initial visit. Erectile dysfunction is indirectly related to the score.
Ankle-Brachial Index (ABI)Procedure or surgery
Also called Multi Dopplex II 8-mHz
Measure Ankle-Brachial Index with a hand held doppler and sphygmomanometer to determine the ABI.
What is being measured
The primary outcome is the main question the study is designed to answer.
Sexual Health Inventory for Men (SHIM)
Measured: initial visit
Secondary outcomes (1)
Ankle-Brachial Index (ABI)
Measured: Initial Visit
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Aug 2008 (estimated)
- Study startFeb 2005
- Primary completionFeb 2008
- Study completionMay 2008
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (17)Papers the sponsor has linked to this study.
- Other trials for Erectile DysfunctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 175 participants (actual)
Sponsor and investigators
- Lead sponsor
- Bruton Avenue Family Practice
- Sponsor type
- University, hospital or other
- Collaborators
- Pfizer
- Investigators
- James T Edwards, Jr, MS, MD, Principal investigator, Bruton Avenue Family Practice
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00743613
- Sponsor's protocol ID
- PREPARED 001
- Acronym
- PREPARED
- Status last verified
- Sep 2008
- First submitted
- 28 Aug 2008
- Last updated
- 3 Sep 2008
- Results posted
- No
- Data monitoring committee
- No
Publications
Grover SA, Lowensteyn I, Kaouache M, Marchand S, Coupal L, DeCarolis E, Zoccoli J, Defoy I. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med. 2006 Jan 23;166(2):213-9. doi: 10.1001/archinte.166.2.213.
PubMed 16432091Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, Fratino P, Solerte SB, Garzaniti A. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation. 2004 Jul 6;110(1):22-6. doi: 10.1161/01.CIR.0000133278.81226.C9. Epub 2004 Jun 21.
PubMed 15210604Lue TF. Erectile dysfunction. N Engl J Med. 2000 Jun 15;342(24):1802-13. doi: 10.1056/NEJM200006153422407. No abstract available.
PubMed 10853004Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003 Mar;89(3):251-3. doi: 10.1136/heart.89.3.251.
PubMed 12591819Jackson G. Endothelial function and dysfunction. Int J Clin Pract. 2004 May;58(5):431. doi: 10.1111/j.1368-5031.2004.00255.x. No abstract available.
PubMed 15206495Deedwania PC. Endothelium: a new target for cardiovascular therapeutics. J Am Coll Cardiol. 2000 Jan;35(1):67-70. doi: 10.1016/s0735-1097(99)00536-7. No abstract available.
PubMed 10636261Hurairah H, Ferro A. The role of the endothelium in the control of vascular function. Int J Clin Pract. 2004 Feb;58(2):173-83. doi: 10.1111/j.1368-5031.2004.0103.x. No abstract available.
PubMed 15055866Kloner RA. Erectile dysfunction in the cardiac patient. Curr Urol Rep. 2003 Dec;4(6):466-71. doi: 10.1007/s11934-003-0028-9.
PubMed 14622500Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997 Jun;49(6):822-30. doi: 10.1016/s0090-4295(97)00238-0.
PubMed 9187685Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res. 2005 Jul-Aug;17(4):307-19. doi: 10.1038/sj.ijir.3901327.
PubMed 15875061Sutton-Tyrrell K, Rihal C, Sellers MA, Burek K, Trudel J, Roubin G, Brooks MM, Grogan M, Sopko G, Keller N, Jandova R. Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol. 1998 Feb 15;81(4):375-81. doi: 10.1016/s0002-9149(97)00934-x.
PubMed 9485122Carman TL, Fernandez BB Jr. A primary care approach to the patient with claudication. Am Fam Physician. 2000 Feb 15;61(4):1027-32, 1034.
PubMed 10706155Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001 Sep 19;286(11):1317-24. doi: 10.1001/jama.286.11.1317.
PubMed 11560536Champion H. Erectile Dysfunction and Cardiovascular Disease: Carrots, Sticks, and Better Men's Health. Adv Stud Med. 6(4):163-170, 2006
Vinick A, Richardson D. Erectile Dysfunction in Diabetes. Diabetic Reviews 6:16-33, 1998.
Study at a glance
From the registry record, last updated by the sponsor on 3 Sep 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Predicting Peripheral Arterial Disease in Men With Erectile Dysfunction
- ClinicalTrials.gov ID
- NCT00743613
- Acronym / sponsor ID
- PREPARED / PREPARED 001
- Conditions
- Erectile Dysfunction, Peripheral Arterial Disease
- Keywords
- Erectile Dysfunction, ED, Peripheral Arterial Disease, PAD, Ankle-Brachial Index, ABI
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 175 participants (actual)
- Lead sponsor
- Bruton Avenue Family PracticeUniversity, hospital or other
- Collaborators
- Pfizer
- Study start
- Feb 2005
- Primary completion
- Feb 2008 (actual)
- Study completion
- May 2008 (actual)
- First posted
- 29 Aug 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Erectile dysfunction is a common complaint and is found frequently in men with hyperlipidemia, hypertension, diabetes and those who smoke. ED may also be an early warning of peripheral arterial disease. This study is designed to look for a relationship between the degree of ED and the presence of PAD when associated with co-morbid conditions.
Detailed description
Erectile dysfunction (ED) is a common complaint in the primary care office. It is frequently found in men with hyperlipidemia, hypertension, or diabetes, and may also be an early warning of peripheral arterial disease. We looked for a relationship between the degree of ED and the presence of PAD as measured by the Ankle Brachial Index (ABI) associated with co-morbid conditions. Men over the age of 50 with hyperlipidemia, diabetes, hypertension, or tobacco use were asked to complete a Sexual Health Inventory for Men (SHIM). An ABI was measured using a hand held Doppler. 175 men from two urban and three suburban Family Practices in Tidewater Virginia participated. Outcome measures included SHIM scores, ABI, Systolic Blood Pressure, LDL, Hemoglobin A1C and tobacco use. Moderate or severe erectile dysfunction (SHIM < 11.0) was identified in 44% of participants. More than 12.5% of men with severe ED (SHIM < 7.0) had an ABI positive for PAD at 0.95 or less. The results were adjusted for the presence of hyperlipidemia, hypertension, diabetes and tobacco use. Men with hypertension did not demonstrate a significant increase in the frequency of PAD compared to diabetics or smokers. Neither race nor age was found to increase the prevalence of ED. The complaint of erectile dysfunction in men over age 50 should prompt a physician to consider peripheral arterial disease. A simple self-administered SHIM test should help identify men at risk for PAD and suggest further evaluation if the score is 7.0 or less.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 50 years and older
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Men 50 years old or older with either diabetes, hypertension, hyperlipidemia and/or a history of tobacco use.
Key inclusion criteria (2 listed)
- Men 50 years old or older
- Must have a history of diabetes, hypertension, hyperlipidemia and/or a history of tobacco use
Key exclusion criteria (2 listed)
- Men younger than 50 years of age
- No co-morbid condition such as diabetes, hypertension, hyperlipidemia and/or tobacco use.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sexual Health Inventory for Men (SHIM)Also: SHIM, Sexual Health Inventory for MenFive question test with maximum score of 25 points administered on the initial visit. Erectile dysfunction is indirectly related to the score. | Behavioural | – |
| Ankle-Brachial Index (ABI)Also: Multi Dopplex II 8-mHzMeasure Ankle-Brachial Index with a hand held doppler and sphygmomanometer to determine the ABI. | Procedure or surgery | – |
Primary outcome
Sexual Health Inventory for Men (SHIM)
Time frame: initial visit
1 secondary outcome
Ankle-Brachial Index (ABI)
Time frame: Initial Visit
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Sep 2008.
- Results publication: PubMed 16432091Grover SA, Lowensteyn I, Kaouache M, Marchand S, Coupal L, DeCarolis E, Zoccoli J, Defoy I. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med. 2006 Jan 23;166(2):213-9. doi: 10.1001/archinte.166.2.213.
- Results publication: PubMed 15210604Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, Fratino P, Solerte SB, Garzaniti A. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation. 2004 Jul 6;110(1):22-6. doi: 10.1161/01.CIR.0000133278.81226.C9. Epub 2004 Jun 21.
- Results publication: PubMed 10853004Lue TF. Erectile dysfunction. N Engl J Med. 2000 Jun 15;342(24):1802-13. doi: 10.1056/NEJM200006153422407. No abstract available.
- Results publication: PubMed 12591819Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003 Mar;89(3):251-3. doi: 10.1136/heart.89.3.251.
- Results publication: PubMed 15206495Jackson G. Endothelial function and dysfunction. Int J Clin Pract. 2004 May;58(5):431. doi: 10.1111/j.1368-5031.2004.00255.x. No abstract available.
- Results publication: PubMed 10636261Deedwania PC. Endothelium: a new target for cardiovascular therapeutics. J Am Coll Cardiol. 2000 Jan;35(1):67-70. doi: 10.1016/s0735-1097(99)00536-7. No abstract available.
- Results publication: PubMed 15055866Hurairah H, Ferro A. The role of the endothelium in the control of vascular function. Int J Clin Pract. 2004 Feb;58(2):173-83. doi: 10.1111/j.1368-5031.2004.0103.x. No abstract available.
- Results publication: PubMed 14622500Kloner RA. Erectile dysfunction in the cardiac patient. Curr Urol Rep. 2003 Dec;4(6):466-71. doi: 10.1007/s11934-003-0028-9.
- Results publication: PubMed 9187685Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997 Jun;49(6):822-30. doi: 10.1016/s0090-4295(97)00238-0.
- Results publication: PubMed 15875061Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res. 2005 Jul-Aug;17(4):307-19. doi: 10.1038/sj.ijir.3901327.
- Results publication: PubMed 9485122Sutton-Tyrrell K, Rihal C, Sellers MA, Burek K, Trudel J, Roubin G, Brooks MM, Grogan M, Sopko G, Keller N, Jandova R. Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol. 1998 Feb 15;81(4):375-81. doi: 10.1016/s0002-9149(97)00934-x.
- Results publication: PubMed 10706155Carman TL, Fernandez BB Jr. A primary care approach to the patient with claudication. Am Fam Physician. 2000 Feb 15;61(4):1027-32, 1034.
Related trials for Erectile Dysfunction
RecruitingPhase 2
Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy
Erectile Dysfunction Following Radical Prostatectomy, Prostate Cancer
Active, not recruiting
Treatment With Peripheral Nerve Stimulation of the Pudendal Nerve in Patients With Erectile Dysfunction
Erectile Dysfunction, Electric Stimulation
Active, not recruiting
Efficacy of Low-dose Percutaneous Electrical Stimulation in Patients With Erectile Dysfunction.
Pudendal Nerve Injury, Erectile Dysfunction
Recruiting
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
Peyronie Disease, Erectile Dysfunction
Recruiting
Embolosclerotherapy Versus Deep Dorsal Vein Revascularization in Venogenic Erectile Dysfunction
Erectile Dysfunction Due to Venous Disorder, Erectile Dysfunction (ED)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
James T Edwards, Jr, MS, MD principal investigator
Bruton Avenue Family Practice
5 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Erectile Dysfunction and Peripheral Arterial Disease, run by Bruton Avenue Family Practice at 5 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Sep 2008. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 5 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sexual Health Inventory for Men (SHIM) (time frame: initial visit). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00743613, which also lists 17 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2008.